查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1605916

標的蛋白質分解市場，規模，佔有率，趨勢，產業分析報告:各類型，各治療領域，各給藥途徑，各地區 - 市場預測 2025年～2034年

Targeted Protein Degradation Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area, Route of Administration, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2034年，全球目標蛋白降解市場規模預計將達到35.4791億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於精準醫療的進步和生物技術投資的增加，標靶蛋白質降解 (TPD) 市場正在經歷顯著成長。一個關鍵的推動因素是 TPD 能夠靶向以前 "無法治療" 的蛋白質，為癌症和神經退化性疾病等複雜疾病開闢新的治療途徑。

隨著製藥公司與學術機構和高科技公司合作開發新型降解劑，預計在預測期內這一市場開發機會將會增加。個人化醫療的新興趨勢和對小分子療法的日益關注也推動了市場需求。總體而言，由於研究活動和臨床試驗的增加，TPD 市場預計將迅速擴大。

靶向蛋白質降解市場報告亮點

按類型劃分，市場以蛋白質降解靶向嵌合分子 (PROTAC) 領域為主，該領域因其可降解多種蛋白質而被廣泛採用。預計德格羅酰亞胺將在小分子療法的進步的推動下實現快速增長。

從治療領域來看，癌症疾病領域所佔佔有率最大，因為癌症治療很大程度上依賴於標靶蛋白的降解。由於對阿茲海默症等神經退化性疾病的研究不斷增加，神經系統疾病領域預計將快速成長。

從給藥途徑來看，靜脈給藥在市場上佔據主導地位。靜脈給藥特別用於需要直接和受控遞送的治療。

北美以強大的研發活動和藥品投資引領 TPD 市場。由於醫療保健支出增加、生物技術領域成長以及對創新治療的日益關注，亞太地區成為成長最快的地區。

市場上的主要參與者包括 Arvinas、Kymera Therapeutics 和 Nurix Therapeutics。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球標的蛋白質分解市場洞察

  • 市場概述
  • 標的蛋白質分解市場動態
    • 促進因素和機會
      • 擴大腫瘤學應用
      • 增加神經系統疾病治療
    • 阻礙因素和挑戰
      • 藥物開發與臨床驗證的複雜性
  • PESTEL分析
  • 標的蛋白質分解市場應用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球標的蛋白質分解市場:各類型

  • 主要調查結果
  • 簡介
  • Degronimids
  • 免疫調節藥(IMiD)
  • 蛋白質分解標的嵌合體分子(PROTAC)
  • 突發性視網膜變性症候群(SARD)
  • 選擇的雌激素受體分解藥(SERD)
  • 其他

第6章 全球標的蛋白質分解市場:各治療領域

  • 主要調查結果
  • 簡介
  • 發炎性疾病
  • 神經疾病
  • 腫瘤性疾病
  • 呼吸疾病
  • 其他

第7章 全球標的蛋白質分解市場:各給藥途徑

  • 主要調查結果
  • 簡介
  • 口服
  • 靜脈內
  • 其他

第8章 全球標的蛋白質分解市場:各地區

  • 主要調查結果
  • 簡介
    • 標的蛋白質分解市場評估:各地區，2020～2034年
  • 北美
    • 北美:各類型，2020～2034年
    • 北美:各治療領域，2020～2034年
    • 北美:各給藥途徑，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各類型，2020～2034年
    • 歐洲:各治療領域，2020～2034年
    • 歐洲:各給藥途徑，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各類型，2020～2034年
    • 亞太地區:各治療領域，2020～2034年
    • 亞太地區:各給藥途徑，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各類型，2020～2034年
    • 中東·非洲:各治療領域，2020～2034年
    • 中東·非洲:各給藥途徑，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各類型，2020～2034年
    • 南美:各治療領域，2020～2034年
    • 南美:各給藥途徑，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Arvinas
  • Kymera Therapeutics
  • Nurix Therapeutics
  • C4 Therapeutics
  • Foghorn Therapeutics
  • Zymeworks
  • Bristol-Myers Squibb
  • Pfizer
  • AbbVie
  • Molteni Farmaceutici
Product Code: PM5247

The global targeted protein degradation market size is expected to reach USD 3547.91 million by 2034, according to a new study by Polaris Market Research. The report "Targeted Protein Degradation Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area (Inflammatory Disorders, Neurological Disorders, Oncological Disorders, Respiratory Disorders, and Others), Route of Administration, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The targeted protein degradation (TPD) market is experiencing significant growth, driven by advances in precision medicine and increased investments in biotechnology. A key driver is the potential of TPD to target previously "undruggable" proteins, opening new therapeutic avenues for complex diseases such as cancer and neurodegenerative disorders.

Opportunities in this market are expected to rise during the forecast period as pharmaceutical companies collaborate with academic institutions and tech firms to develop novel degraders. The emerging trend toward personalized medicine and the growing focus on small-molecule therapeutics also fuel market demand. Overall, with increasing research activities and clinical trials, the TPD market is poised for rapid expansion.

Targeted Protein Degradation Market Report Highlights:

Based on type, the proteolysis-targeting chimeric molecules (PROTACs) segment dominates the market, being widely adopted due to their ability to degrade a broad range of proteins. Degronimids are expected to witness rapid growth, driven by advancements in small-molecule therapeutics.

In terms of therapeutic area, the oncological disorders segment holds the largest share, as cancer treatments heavily rely on targeted protein degradation. The neurological disorders segment is projected to grow rapidly, with increasing research on neurodegenerative diseases such as Alzheimer's.

By route of administration, the intravenous segment dominates the market; the IV route is especially used for therapies requiring direct and controlled delivery.

North America leads the TPD market, owing to strong R&D activities and pharmaceutical investments. Asia Pacific is the fastest-growing region, driven by rising healthcare expenditure, growing biotechnology sectors, and an increasing focus on innovative therapies.

Some of the key players in the market are Arvinas, Kymera Therapeutics, and Nurix Therapeutics.

Polaris Market Research has segmented the targeted protein degradation market report on the basis of type, therapeutic area, route of administration, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Degronimids
  • Immunomodulatory Drugs (IMiDs)
  • Proteolysis-Targeting Chimeric Molecules (PROTACs)
  • Sudden Acquired Retinal Degeneration Syndrome (SARDs)
  • Selective Estrogen Receptor Degraders (SERDs)
  • Others

By Therapeutic Area Outlook (Revenue - USD Million, 2020-2034)

  • Inflammatory Disorders
  • Neurological Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Others

By Route of Administration Outlook (Revenue - USD Million, 2020-2034)

  • Oral
  • Intravenous
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Targeted Protein Degradation Market Insights

  • 4.1. Targeted Protein Degradation Market - Market Snapshot
  • 4.2. Targeted Protein Degradation Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Expansion in Oncology Applications
      • 4.2.1.2. Rise in Neurological Disorder Treatments
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complexity of Drug Development and Clinical Validation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Targeted Protein Degradation Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Targeted Protein Degradation Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • 5.3. Degronimids
    • 5.3.1. Global Targeted Protein Degradation Market, by Degronimids, by Region, 2020-2034 (USD Million)
  • 5.4. Immunomodulatory Drugs (IMiDs)
    • 5.4.1. Global Targeted Protein Degradation Market, by Immunomodulatory Drugs (IMiDs), by Region, 2020-2034 (USD Million)
  • 5.5. Proteolysis-Targeting Chimeric Molecules (PROTACs)
    • 5.5.1. Global Targeted Protein Degradation Market, by Proteolysis-Targeting Chimeric Molecules (PROTACs), by Region, 2020-2034 (USD Million)
  • 5.6. Sudden Acquired Retinal Degeneration Syndrome (SARDs)
    • 5.6.1. Global Targeted Protein Degradation Market, by Sudden Acquired Retinal Degeneration Syndrome (SARDs), by Region, 2020-2034 (USD Million)
  • 5.7. Selective Estrogen Receptor Degraders (SERDs)
    • 5.7.1. Global Targeted Protein Degradation Market, by Selective Estrogen Receptor Degraders (SERDs), by Region, 2020-2034 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Targeted Protein Degradation Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Targeted Protein Degradation Market, by Therapeutic Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • 6.3. Inflammatory Disorders
    • 6.3.1. Global Targeted Protein Degradation Market, by Inflammatory Disorders, by Region, 2020-2034 (USD Million)
  • 6.4. Neurological Disorders
    • 6.4.1. Global Targeted Protein Degradation Market, by Neurological Disorders, by Region, 2020-2034 (USD Million)
  • 6.5. Oncological Disorders
    • 6.5.1. Global Targeted Protein Degradation Market, by Oncological Disorders, by Region, 2020-2034 (USD Million)
  • 6.6. Respiratory Disorders
    • 6.6.1. Global Targeted Protein Degradation Market, by Respiratory Disorders, by Region, 2020-2034 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Targeted Protein Degradation Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Targeted Protein Degradation Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 7.3. Oral
    • 7.3.1. Global Targeted Protein Degradation Market, by Oral, by Region, 2020-2034 (USD Million)
  • 7.4. Intravenous
    • 7.4.1. Global Targeted Protein Degradation Market, by Intravenous, by Region, 2020-2034 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Targeted Protein Degradation Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Targeted Protein Degradation Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Targeted Protein Degradation Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Targeted Protein Degradation Market - North America
    • 8.3.1. North America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.3.3. North America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.3.4. Targeted Protein Degradation Market - US
      • 8.3.4.1. US: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.3.4.2. US: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.3.4.3. US: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.3.5. Targeted Protein Degradation Market - Canada
      • 8.3.5.1. Canada: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 8.4. Targeted Protein Degradation Market - Europe
    • 8.4.1. Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.4.3. Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.4. Targeted Protein Degradation Market - UK
      • 8.4.4.1. UK: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.5. Targeted Protein Degradation Market - France
      • 8.4.5.1. France: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.5.3. France: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.6. Targeted Protein Degradation Market - Germany
      • 8.4.6.1. Germany: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.7. Targeted Protein Degradation Market - Italy
      • 8.4.7.1. Italy: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.8. Targeted Protein Degradation Market - Spain
      • 8.4.8.1. Spain: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.9. Targeted Protein Degradation Market - Netherlands
      • 8.4.9.1. Netherlands: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.10. Targeted Protein Degradation Market - Russia
      • 8.4.10.1. Russia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.11. Targeted Protein Degradation Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 8.5. Targeted Protein Degradation Market - Asia Pacific
    • 8.5.1. Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.4. Targeted Protein Degradation Market - China
      • 8.5.4.1. China: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.4.3. China: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.5. Targeted Protein Degradation Market - India
      • 8.5.5.1. India: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.5.3. India: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.6. Targeted Protein Degradation Market - Malaysia
      • 8.5.6.1. Malaysia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.7. Targeted Protein Degradation Market - Japan
      • 8.5.7.1. Japan: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.8. Targeted Protein Degradation Market - Indonesia
      • 8.5.8.1. Indonesia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.9. Targeted Protein Degradation Market - South Korea
      • 8.5.9.1. South Korea: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.10. Targeted Protein Degradation Market - Australia
      • 8.5.10.1. Australia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.11. Targeted Protein Degradation Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 8.6. Targeted Protein Degradation Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.4. Targeted Protein Degradation Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.5. Targeted Protein Degradation Market - UAE
      • 8.6.5.1. UAE: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.6. Targeted Protein Degradation Market - Israel
      • 8.6.6.1. Israel: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.7. Targeted Protein Degradation Market - South Africa
      • 8.6.7.1. South Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.8. Targeted Protein Degradation Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • 8.7. Targeted Protein Degradation Market - Latin America
    • 8.7.1. Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.4. Targeted Protein Degradation Market - Mexico
      • 8.7.4.1. Mexico: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.5. Targeted Protein Degradation Market - Brazil
      • 8.7.5.1. Brazil: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.6. Targeted Protein Degradation Market - Argentina
      • 8.7.6.1. Argentina: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.7. Targeted Protein Degradation Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Arvinas
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Kymera Therapeutics
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Nurix Therapeutics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. C4 Therapeutics
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Foghorn Therapeutics
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Zymeworks
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Bristol-Myers Squibb
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Pfizer
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. AbbVie
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Molteni Farmaceutici
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 2 Global Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 3 Global Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 4 North America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 5 North America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 6 North America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 7 US: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 8 US: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 9 US: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 10 Canada: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 11 Canada: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 12 Canada: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 13 Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 14 Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 15 Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 16 UK: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 17 UK: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 18 UK: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 19 France: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 20 France: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 21 France: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 22 Germany: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 23 Germany: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 24 Germany: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 25 Italy: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 26 Italy: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 27 Italy: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 28 Spain: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 29 Spain: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 30 Spain: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 31 Netherlands: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 33 Netherlands: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 34 Russia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 35 Russia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 36 Russia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 43 China: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 44 China: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 45 China: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 46 India: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 47 India: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 48 India: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 49 Malaysia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 51 Malaysia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 52 Japan: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 53 Japan: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 54 Japan: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 55 Indonesia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 57 Indonesia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 58 South Korea: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 60 South Korea: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 61 Australia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 62 Australia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 63 Australia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 73 UAE: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 74 UAE: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 75 UAE: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 76 Israel: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 77 Israel: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 78 Israel: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 79 South Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 81 South Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 85 Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 87 Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 88 Mexico: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 90 Mexico: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 91 Brazil: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 93 Brazil: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 94 Argentina: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 96 Argentina: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global Targeted Protein Degradation Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Targeted Protein Degradation Market, by Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Therapeutic Area
  • Figure 9. Global Targeted Protein Degradation Market, by Therapeutic Area, 2024 & 2034 (USD Million)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Targeted Protein Degradation Market, by Route of Administration, 2024 & 2034 (USD Million)